Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr
The 33% year-over-year revenue growth and a remarkable 45% surge in gross profit reflect our strong market presence and efficient execution across therapeutic segments
The 33% year-over-year revenue growth and a remarkable 45% surge in gross profit reflect our strong market presence and efficient execution across therapeutic segments
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
Teriflunomide is a novel disease-modifying agent that was approved for use in the treatment of multiple sclerosis
The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
The Acetaminophen and Ibuprofen tablets will be manufactured at the company’s flagship facility in KRSG, Bengaluru
Jemperli plus chemotherapy is the only immuno-oncology-based treatment to show statistically significant and clinically meaningful OS benefit in the overall population
Mesalazine is used to treat inflammatory bowel disease
The company ensures a reliable and strong portfolio at competitive prices without compromising on excellent quality
Subscribe To Our Newsletter & Stay Updated